{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:16:30Z","timestamp":1793812590329,"version":"4.6.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Parkinson\u2019s disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms. During Ramadan, fasting Muslims abstain from food, drink, and often medications between sunrise and sunset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To review the clinical considerations, therapeutic strategies, and cultural factors relevant to managing PD patients during Ramadan fasting, and to provide practical recommendations for neurologists and healthcare providers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This review synthesized existing guidelines (e.g., BIMA Ramadan Compendium), literature on drug pharmacokinetics during fasting, and clinical expertise from PD specialists in Middle Eastern and global Muslim populations. Discussions at a PD consensus meeting informed a stepwise algorithm for individualized care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Pre-Ramadan risk assessment is essential, with stratification by disease stage. Early PD (Hoehn and Yahr stage 1\u20132) patients on monotherapy may fast safely with minimal adjustments, while moderate PD (Hoehn and Yahr stage 3) with multiple daily levodopa doses or combination therapy, requires consolidation of levodopa doses, addition of long-acting agents, and avoidance of dose stacking. Advanced PD patients who have troublesome motor\/non-motor fluctuations and dyskinesias as well, and are taking medications multiple times per day are often unsuitable for fasting. Common complications include response fluctuations, dyskinesias, and sleep disturbances exacerbated by altered circadian rhythms. Long-acting dopaminergic therapies, including Dopamine Agonists (rotigotine patches and other extended-release (ER) oral agents), adjunctive agents (opicapone, rasagilline and safinamide), and Device-Aided Treatments (DAT; subcutaneous foslevodopa-foscarbidopa, subcutaneous continous subcutaneous apomorphine infusion, levodopa-carbidopa intestinal gel and deep brain stimulation) can help stabilize motor and non-motor fluctuations. Sleep hygiene measures and behavioral adjustments further support patient well-being. Cultural and spiritual motivations strongly influence adherence, requiring sensitive counseling and involvement of caregivers and religious leaders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Safe Ramadan fasting in PD requires comprehensive pre-Ramadan assessment, stage-specific therapeutic strategies, and proactive management of both motor and non-motor complications. Shared decision-making that integrates medical, psychological, and religious considerations is vital to optimize patient outcomes while respecting spiritual values.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2025.1720571","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T15:49:09Z","timestamp":1765554549000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Faith, fasting, and well-being: Emirates Neurology Society consensus guidelines on safe Ramadan fasting in Parkinson\u2019s disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Shivam Om","family":"Mittal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Krystkowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl Johan","family":"Ramberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pournamy","family":"Sarathchandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Iantorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Cirasanambati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Al Aloma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanmoy","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhail","family":"Al Rukn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1212\/WNL.0b013e3181a1d44c","article-title":"The scientific and clinical basis for the treatment of Parkinson disease","volume":"72","author":"Olanow","year":"2009","journal-title":"Neurology"},{"key":"ref2","volume-title":"Ramadan compendium","year":"2021"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.neurol.2018.12.008","article-title":"How do Parkinson's disease patients manage Ramadan fasting? An observational study","volume":"175","author":"Kamel","year":"2019","journal-title":"Rev Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"682184","DOI":"10.3389\/fneur.2021.682184","article-title":"The role of intermittent fasting in Parkinson's disease","volume":"12","author":"Neth","year":"2021","journal-title":"Front Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1485632","DOI":"10.3389\/fnut.2024.1485632","article-title":"Intermittent fasting, fatty acid metabolism reprogramming, and neuroimmuno microenvironment: mechanisms and application prospects","volume":"11","author":"Zhang","year":"2024","journal-title":"Front Nutr"},{"key":"ref6","volume-title":"Spiritual benefits from the spiritual point of view, the ultimate objective of fasting is spiritual betterment, as Allah himself signified in the holy Quran: O believers! Fasting is prescribed for you\u2014As it was for those before you-so perhaps you will become mindful of Allah. (holy Quran: 183\/02) some of the most imperative benefits are","author":"Shaikh","year":"2024"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"109212","DOI":"10.1016\/j.jnutbio.2022.109212","article-title":"Intermittent fasting protects the nigral dopaminergic neurons from MPTP-mediated dopaminergic neuronal injury in mice","volume":"112","author":"Ojha","year":"2023","journal-title":"J Nutr Biochem"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.3390\/nu11102501","article-title":"Fasting as a therapy in neurological disease","volume":"11","author":"Phillips","year":"2019","journal-title":"Nutrients"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.psychres.2012.12.018","article-title":"Fasting in mood disorders: neurobiology and effectiveness. A review of the literature","volume":"209","author":"Fond","year":"2013","journal-title":"Psychiatry Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.3390\/nu13093166","article-title":"The effects of intermittent fasting on brain and cognitive function","volume":"13","author":"Gudden","year":"2021","journal-title":"Nutrients"},{"key":"ref11","volume-title":"Fasting and me [internet]","author":"Hussain-Ali","year":"2023"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1756285617737728","DOI":"10.1177\/1756285617737728","article-title":"Extended-release oral capsule of carbidopa-levodopa in Parkinson disease","volume":"11","author":"Margolesky","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"ref13","first-page":"e001215","article-title":"Understanding the progression of Parkinson\u2019s disease: a review","volume-title":"BMJ Neurol Open","author":"Kempster","year":"2025"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.4081\/ni.2017.7043","article-title":"The effects of fasting during ramadan on the concentration of serotonin, dopamine, brain-derived neurotrophic factor and nerve growth factor","volume":"9","author":"Bastani","year":"2017","journal-title":"Neurol Intt"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.3233\/JPD-212749","article-title":"Management of sleep disturbances in Parkinson\u2019s disease","volume":"12","author":"Sch\u00fctz","year":"2022","journal-title":"J Parkinsons Dis"},{"key":"ref16","volume-title":"Parkinson\u2019s disease: Sleep disturbances and fatigue","year":"2025"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1001\/jamaneurol.2016.4291","article-title":"Treatment of patients with Parkinson disease during Ramadan","volume":"74","author":"Damier","year":"2017","journal-title":"JAMA Neurol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/1877718X241306711","article-title":"Opicapone for Parkinson\u2019s disease-related sleep disturbances: The OASIS clinical trial","volume":"15","author":"Ferreira","year":"2025","journal-title":"J Parkinsons Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s10865-011-9348-2","article-title":"Prayer and pain: the mediating role of positive re-appraisal","volume":"34","author":"Dezutter","year":"2011","journal-title":"J Behav Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.socscimed.2005.11.055","article-title":"Do religious\/spiritual coping strategies affect illness adjustment in patients with cancer? A systematic review of the literature","volume":"63","author":"Keshtgar","year":"2006","journal-title":"Soc Sci Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1367467032000157981","article-title":"Religion, spirituality, and posttraumatic growth: a systematic review","volume":"8","author":"Shaw","year":"2005","journal-title":"Ment Health Relig Cult"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2147\/nedt.2006.2.3.341","article-title":"Religiosity in patients with Parkinson\u2019s disease","volume":"2","author":"McNamara","year":"2006","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/09638289709166439","article-title":"Coping with chronic neurological impairment: a contrastive analysis of Parkinson's disease and stroke","volume":"19","author":"Herrmann","year":"1997","journal-title":"Disabil Rehabil"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1720571\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T15:49:11Z","timestamp":1765554551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1720571\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":23,"alternative-id":["10.3389\/fneur.2025.1720571"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1720571","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"article-number":"1720571"}}